Las Vegas, NV -- (SBWIRE) -- 01/07/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: Cannabis Science Inc(OTCMKTS:CBIS), ENDEXX CORP(OTCMKTS:EDXC), Nuvilex Inc(OTCMKTS:NVLX), AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS)
Cannabis Science Inc(OTCMKTS:CBIS) ended higher 14.21% and complete the day at $0.0691. The total number of shares changed hands during the day was 33.75 million. After opening at $0.06, the stock hit as high as $0.07. However, it traded between $0.03 and $0.12 over the last twelve months. Cannabis Science, Inc. is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.
For How Long CBIS will Fight for Profitability? Read This Trend Analysis report
ENDEXX CORP(OTCMKTS:EDXC) closed yesterday at $0.0750, a +7.91% increase. Around 4.70 million shares were traded, beating an-average trading volume of 615,761 shares. The company is now valued at around $9.00 million. ENDEXX Corp., through its subsidiaries, provides platforms for entrepreneurs. It offers m3Hub, a platform that manages patient concentric data and incorporates best patient privacy practices through verification, privacy, legal, and transparent controls, as well as legitimizes the entire transaction process on behalf of patients.
For How Long EDXC Gloss will Attract Investors? Find out via this report
Nuvilex Inc(OTCMKTS:NVLX) moved +4.80 percent higher at $0.120 and traded between $0.12 and $0.12 after opening the day at $0.12. Its performance over the last five days remained 13.74%, which stands at -5.51% for a month. Going back further than one month, 1-year performance after recent close was 17.65%. Nuvilex, Inc. operates independently and through wholly owned subsidiaries. The Company is a biotechnology and life technology company with a specialty in living-cell encapsulation.
For How Long NVLX Gloss will Attract Investors? Find out via this report
AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) shares rose, gaining 16.10 percent to close at $0.075. Around 10.94 million shares changed hands yesterday. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
Why Should Investors Buy AMBS After The Recent Gain? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)